Contacter le RP
Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.
Babbler permet aux journalistes et communicants de collaborer plus simplement.
En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !
Leurs espaces presse sont sur Babbler :
Vous êtes à 1 clic de l'inscription !
Content de vous revoir !
Gene Synthesis Market Industry Growth, Trends, Outlook, and Analysis, 2018-2026
minutes de lecture
minute de lecture
Gene synthesis is chemically in vitro synthesis of double-stranded DNA molecules. It is a technology used in biotechnology and plays an important role in the field of synthetic biology. The technology has become a significant tool in various fields of recombinant DNA technology including gene therapy, vaccine development, molecular engineering, and heterologous gene expression. It can help in designing novel enzymes for cancer treatment. Also, it can be used in diagnosis of viral genomes for vaccine development in real-time. Gene synthesis can develop mutated, recombinant, or entirely novel DNA sequences without any template DNA strand. Moreover, it can also synthesize, oligos and RNA containing modified bases or chimeric DNA-RNA backbones along with DNA sequences.
Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1533
Custom gene synthesis derives from oligonucleotide synthesis technology and is the gold standard method for synthesis of PCR primers. Gene synthesis builds on this platform and uses exclusive technologies to join the oligos to synthesize full gene sequence. The price for custom gene synthesis was around US$ 0.69/base, earlier. Gene synthesis is a useful codon optimization tool to circumvent codon bias problems during heterologous protein expression. Protein expression can be improved considerably by designing DNA sequences with only codons preferred by the intended expression host.
Increasing R&D associated with gene synthesis coupled with continuous improvement in the technological processes such as molecular separation and protein purification technology helps in developing reliable, fast, and cost effective solutions. In recent years, gene synthesis has advanced with innovations in DNA as a data storage device and re-engineered genomes. Next-generation gene synthesis provides highly accurate constructs in greater numbers and at comparatively lower prices than has been possible so far.
Solid-phase synthesis is highly accurate, however, is an expensive process and offers low output. Chip-based DNA synthesis is less expensive than solid-phase method and can produce a large amount of the target gene, however, with less accuracy. PCR-based enzyme synthesis produces gene fragments with a variety of cell systems. It synthesizes long gene fragments with higher accuracy. Gene synthesis methods have a profound impact in vaccine design, genetic and metabolic engineering. However, currently available methods are inconsistent with drawbacks such as high error rate, low yield, and lack of scalability on the size of the gene and size of the project.
Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1533
Major players operating in the gene synthesis market include Atum, ATDBio Ltd., Bioneer Corporation, Eurofins Scientific, Eurogentec, GenScript Biotech Corporation, Genewiz, Integrated DNA Technologies, Inc., OriGene Technologies, Inc., and Thermo Fisher Scientific, Inc. Companies are focusing on strengthening their sales force and expanding their production facilities in various geographies. For instance, in 2016, Eurofins Lancaster Laboratories (Eurofins Scientific), announced strategic plans for expansion of its Ireland campus, including development of a new building, expansion of its facility, and increase its workforce. The International Gene Synthesis Consortium (IGSC) is a group of gene synthesis organizations and companies that applies and designs a common method to screen sequences of synthetic gene orders. The group also works with international and national government organizations. Currently, the IGSC members together comprises around 80% of commercial gene synthesis capacity worldwide.
Companies are focusing on strengthening their sales force and expanding their production facilities in various geographies. For instance, in 2016, Eurofins Lancaster Laboratories (Eurofins Scientific), announced strategic plans for expansion of its Ireland campus, including development of a new building, expansion of its facility, and increase its workforce.
Market Taxonomy: By Product Type, Gene Library Synthesis, Custom Gene Synthesis, By Method: Solid Phase Synthesis, Chip based DNA synthesis, PCR based enzyme synthesis, .By End User: Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations,.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Visit our news Website: https://www.coherentwire.com
- Business Consulting Services
- Communications & Marketing
- Company News & Announcements
- + 3
- Health & Medicine
- Sales & Marketing
Autres actualités de la marque
Félicitations, vous êtes inscrit sur BABBLER !
Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !
Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici
- Business Consulting Services
- Communications & Marketing